Kakihana et al., J Thorac Oncol 2009
(Carcinoma, Non-Small-Cell Lung...) :
Induction of E-cadherin in lung cancer and interaction with growth suppression by histone deacetylase inhibition
Suda et al., J Thorac Oncol 2011
(Adenocarcinoma...) :
We also found that the histone deacetylase inhibitor, MS-275, restored E-cadherin expression and moderate sensitivity to erlotinib in HCC4006ER cells, on the other hand, transforming growth factor beta, an inducer of EMT, led to moderate erlotinib resistance in HCC4006 parental cells